 |
Oklahoma Administrative Code (Last Updated: March 11, 2021) |
 |
TITLE 310. Oklahoma State Department of Health |
|
Chapter 551. Advancement in Stem Cell Cures and Therapies Act |
|
Subchapter 1. General Provisions |
SECTION 310:551-1-2. Definitions
Latest version.
- The following words or terms, when used in this Chapter, shall have the following meaning, unless the context clearly indicates otherwise."Adult stem cell" means undifferentiated cells, found throughout the body after embryonic development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. These stem cell types include but are not limited to, Adipose stem cells (ASC), Connective Tissue Progenitors (CTP), Hematopoietic stem cells (HSC), Hemangioblast (AC133) from umbilical cell blood (HB1), Mesenchymal Stem Cells (MSC), Multi-potent adult stem cells (MAPC), Neural stem cells/oligodendrocyte progenitors (NSC), Skeletal myoblast (SKMS), and Umbilical cord blood derived stem cells (UCB)."Board" means the Oklahoma State Board of Health."Classification" means the business form of the information provider."Commissioner" means the Commissioner of the Oklahoma State Department of Health or his designated representative."Completed report" means a submitted data file that has been reviewed by the Department and found to contain no observed errors."Data element" means a unit of specific information collected and recorded by the Department that identifies the persons and entities engaged in stem cell research in Oklahoma and the nature of the stem cell research being conducted."Data file" means an electronic file containing data elements."Data provider" means either an information provider or an IRB who agrees to provide informationon behalf of an information provider."Department" means the Oklahoma State Department of Health."Donor" means the person or entity with legal custody of a fertilyzed egg or oocyte."Embryonic stem cell" means cells derived from embryos that develop from eggs that have been fertilized in vitro and then lawfully donated for research purposes with informed consent of the donor."Human Embryo" refers to a living organism of the species Homo sapiens at the earliest stage of development, including the single-cell stage, that is not located in the body of a woman. [1-270.2 of Title 63]"Human tissue regeneration" means any cell-based therapy that involves the regeneration of human tissue using stem cells."Information provider" means a private or public institution or other entity, or a person who is not affiliated with an institution or entity, that has initiated or is conducting research."IRB" or "Institutional Review Board" means the body or committee that is established in accordance with federal law and charged with the responsibility to provide oversight functions within a private or public institution where biomedical research involving human subjects is being conducted or performed. An IRB may include a Stem Cell Research Oversight Committee."Research" means any work, labor or effort into discovering, discerning or advancing knowledge of the science of cell regeneration."Somatic cell nuclear transfer" means a laboratory technique for creating an ovum with a donor nucleus."Stem cell" means an adult stem cell or an embryonic stem cell.